CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 1 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $16,722,000 | -55.6% | 600,000 | -70.9% | 0.14% | -60.3% |
| Q4 2014 | $37,635,000 | +33.1% | 2,062,200 | -5.5% | 0.36% | +22.0% |
| Q3 2014 | $28,274,000 | -20.6% | 2,181,600 | 0.0% | 0.30% | -29.4% |
| Q2 2014 | $35,604,000 | -14.2% | 2,181,600 | -7.1% | 0.42% | -18.0% |
| Q1 2014 | $41,482,000 | +30.7% | 2,347,600 | +79.1% | 0.51% | +9.4% |
| Q4 2013 | $31,730,000 | – | 1,310,600 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |